Baird Medical Investment (BDMD) vs Nephros (NEPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Nephros (NEPH) has outperformed Baird Medical Investment (BDMD) over the past year, losing 43.7% versus a loss of 54.6%. Nephros is the larger company by market cap ($35.7 million vs $25.4 million), about 1.4 times the size. On valuation, Baird Medical Investment trades at a lower forward P/E (5.6x vs 15.7x for Nephros).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDMD | NEPH |
|---|---|---|
| Share price | $0.79 | $3.29 |
| Market cap | $25.37M | $35.73M |
| 1-day change | 0.00% | +2.81% |
| YTD return | -41.91% | -34.43% |
| 1-year return | -54.60% | -43.66% |
| 5-year return | — | -58.76% |
| P/E ratio (TTM) | — | 21.93 |
| Forward P/E | 5.64 | 15.67 |
| EPS (TTM) | $-0.55 | $0.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.70 | $6.42 |
| 52-week low | $0.661 | $2.66 |
| Distance from 52-week high | -78.65% | -48.75% |
| Average volume | 52.95K | 25.58K |
| Shares outstanding | 32.11M | 10.86M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NEPH has outperformed BDMD by 10.9 percentage points over the past year.
BDMD vs NEPH FAQ
Which is bigger, Baird Medical Investment or Nephros?
Nephros (NEPH) is larger, with a market capitalization of $35.73M compared with $25.37M for Baird Medical Investment (BDMD).
Which stock has performed better over the past year, BDMD or NEPH?
NEPH returned -43.66% over the past 12 months, compared with -54.60% for BDMD (price return, excluding dividends). Past performance does not predict future results.
Are Baird Medical Investment and Nephros in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.